Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.29
    -0.05 (-2.14%)
    At close: Aug 15, 2025, 12:47 PM

    InMed Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 6.29M 5.48M 1.4M n/a
    Cost of Revenue
    		 4.78M 3.62M 702.87K 197.03K
    Gross Profit
    		 1.51M 1.86M 699.85K -197.03K
    Operating Income
    		 -11.12M -11.1M -17.76M -9.92M
    Interest Income
    		 721.97K 652.37K 123.72K 16.02K
    Pretax Income
    		 -10.49M -10.51M -23.95M -10.2M
    Net Income
    		 -10.5M -10.53M -23.95M -10.2M
    Selling & General & Admin
    		 7.18M 7.75M 8.84M 4.48M
    Research & Development
    		 5.15M 4.94M 9.38M 5.34M
    Other Expenses
    		 300.33K 267.93K 239.05K 120.87K
    Operating Expenses
    		 12.63M 12.96M 18.46M 9.94M
    Interest Expense
    		 n/a n/a n/a 360.35K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 17.41M 16.58M 19.16M 9.94M
    Income Tax Expense
    		 9.71K 17.35K n/a 360.35K
    Shares Outstanding (Basic)
    		 762.11K 244.54K 56.08K 26.88K
    Shares Outstanding (Diluted)
    		 762.11K 244.85K 56.08K 26.88K
    EPS (Basic)
    		 -10.07 -43 -426.9 -470.6
    EPS (Diluted)
    		 -10.07 -43.1 -427 -470.6
    EBITDA
    		 -10.3M -10.31M -17.1M -9.8M
    EBIT
    		 -11.12M -11.1M -17.76M -12.29M
    Depreciation & Amortization
    		 826.76K 789.55K 658.96K 197.03K

    Add to Watchlist